Xenograft and Syngeneic Cancer Cell Lines
(Alphabetical list )
Cell Line |
Tumor Type |
Tissue of Origin |
Species |
A375 |
Melanoma |
Skin |
Human |
A-549 |
Carcinoma |
Lung |
Human |
A-673 |
Rhabdomyosacroma |
Muscle |
Human |
AR42J |
Carcinoma |
Pancreas |
Rat |
B-16-F10 |
Melanoma |
Skin |
Murine |
CaKi-2 |
Clear Cell Carcinoma |
Kidney |
Human |
DU-145 |
Adenocarcinoma |
Prostate |
Human |
FaDu |
Squamous Cell Carcinoma |
Pharynx |
Human |
HCT-116 |
Adenocarcinoma |
Colon |
Human |
HCT-25 |
Adenocarcinoma |
Colon |
Human |
HeLa |
Adenocarcinoma |
Cervix |
Human |
HT-1080 |
Fibrosarcoma |
Connective Tissue |
Human |
HT-29 |
Adenocarcinoma |
Colon |
Human |
JEG-3 |
Choriocarcinoma |
Placenta |
Human |
Lewis Lung |
Carcinoma |
Lung |
Murine |
LnCap tumor |
Carcinoma |
prostate |
Human |
MatBIII |
Mammary carcinoma |
Breast |
Rat |
MatLu |
Carcinoma |
Prostate |
Rat |
MCF-7 |
Adenocarcinoma |
Breast |
Human |
MDA-MB-231 |
Adenocarcinoma |
Breast |
Human |
MIA PaCa-2 |
Carcinoma |
Pancreas |
Human |
NCI-H460 |
Large Cell Carcinoma |
Lung |
Human |
OVCAR-3 |
Adenocarcinoma |
Ovary |
Human |
Panc-1 |
Epithelioid Carcinoma |
Pancreas, Duct |
Human |
PC-3 |
Adenocarcinoma |
Prostate |
Human |
R230 |
Adenocarcinoma |
Rat |
|
SKOV-3 |
Adenocarcinoma |
Ovary |
Human |
SW-480 |
Adenocarcinoma |
Colon |
Human |
SW-780 |
Transitional Cell Carcinoma |
Urinary Bladder |
Human |
Chemotherapeutic Agents Used as Positive Controls
- Cisplatin
- Paclitaxel (Taxol)
- Methotrexate
- 5-Flurouracil (5-FU)
- Doxorubicin
- Irinotecan (Camptosar)
- Mitomycin C
- Cyclophosphamide
- Tamoxifen
- Gemcitabine (Gemzar)